Rockefeller Capital Management
GOSS icon

Rockefeller Capital Management’s Gossamer Bio GOSS Stock Holding History

Rockefeller Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.4K Buy
107,615
+46,749
+77% +$73.5K ﹤0.01% 3447
2025
Q4 		$189K Buy
60,866
+50,666
+497% +$145K ﹤0.01% 2409
2025
Q3 		$26.8K Buy
+10,200
New +$22.5K ﹤0.01% 3204
2023
Q1 		– Sell
-4
Closed – – 2763
2022
Q4 		$0 Hold
4
– – ﹤0.01% 3995
2022
Q3 		$0 Hold
4
– – ﹤0.01% 4068
2022
Q2 		$0 Hold
4
– – ﹤0.01% 4216
2022
Q1 		$0 Hold
4
– – ﹤0.01% 3947
2021
Q4 		$0 Hold
4
– – ﹤0.01% 3850
2021
Q3 		$0 Buy
+4
New +$37 ﹤0.01% 3739

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Rockefeller Capital Management's GOSS Position: Q1 2026 in Review

Rockefeller Capital Management increased its Gossamer Bio (GOSS) stake by 77% in Q1 2026, buying an estimated $73.5K and bringing the position to 107,615 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3447.

Rockefeller Capital Management first reported a position in GOSS in Q3 2021 and has held it in 9 quarters since. The position peaked at $189K in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Rockefeller Capital Management held 107,615 shares of Gossamer Bio worth $35.4K as of Q1 2026.
  • Rockefeller Capital Management bought 46,749 Gossamer Bio shares in Q1 2026, an estimated $73.5K.
  • Gossamer Bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3447 holding.
  • Rockefeller Capital Management first reported a position in Gossamer Bio in Q3 2021 and has held it in 9 quarters since.
  • Rockefeller Capital Management's Gossamer Bio position peaked at $189K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.